{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:16:16Z","timestamp":1747224976647,"version":"3.40.5"},"reference-count":21,"publisher":"Galenos Yayinevi","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2022,4,29]]},"DOI":"10.4274\/tjps.galenos.2021.58047","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T14:04:43Z","timestamp":1629813883000},"page":"125-131","source":"Crossref","is-referenced-by-count":4,"title":["Design, Development, Optimization and Evaluation of Ranolazine Extended Release Tablets"],"prefix":"10.4274","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4271-8614","authenticated-orcid":false,"given":"Raghavendra Kumar","family":"GUNDA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-4538","authenticated-orcid":false,"given":"Prasada Rao","family":"MANCHINENI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9922-2636","authenticated-orcid":false,"given":"DDhachinamoorthi","family":"DURAISWAMY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-7133","authenticated-orcid":false,"given":"Koteswara Rao","family":"GSN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"ref0","unstructured":"1. Remington. The science and practice of pharmacy. (21st ed). USA; Lippincott, Williams and Wilkins Publications; 2005:939-964."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/0973-8398.91992","article-title":"Formulation and evaluation of ranolazine extended release tablets: influence of polymers","volume":"5","author":"Tegk","year":"2011","unstructured":"2. Tegk M, Mukkala BVP, Babu VV S. Formulation and evaluation of ranolazine extended release tablets: influence of polymers. Asian J Pharm. 2011;5:162-166.","journal-title":"Asian J Pharm"},{"key":"ref2","unstructured":"3. Adepu H, Srilatha S, Reddy MR. Formulation and evaluation of film coated ranolazine extended release tablets. Int J Inn Pharm Sci Res. 2014;2:2283-2294."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3329\/dujps.v8i1.5333","article-title":"In vitro release kinetics study of ranolazine from swellable hydrophilic matrix tablets","volume":"8","author":"Uddin","year":"2009","unstructured":"4. Uddin NM, Ahmed I, Roni MA, Islam MR, Rahman MH, Ul Jalil R. In vitro release kinetics study of ranolazine from swellable hydrophilic matrix tablets. Dhaka Univ J Pharm Sci. 2009;8:31-38.","journal-title":"Dhaka Univ J Pharm Sci"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Gunda RK, Vijayalakshmi A. Formulation development and evaluation of gastro retentive bioadhesive drug delivery system for moxifloxacin. HCl. Ind J Pharm Edu Res. 2019;53:724-732.","DOI":"10.5530\/ijper.53.4.137"},{"key":"ref5","unstructured":"6. Jitendra G, Govind M, Prabakaran L, Reena G. Formulation development and characterization of modified release microspheres of antianginal. Drug Int J Drug Dev Res. 2014;6:252-265."},{"key":"ref6","unstructured":"7. Bawankar DL, Deshmane SV, More SM, Channawar MA, Chandewar AV, Shreekanth J. Design and characterization of extended release ranolazine matrix tablet. Res J Pharm Tech. 2009;2:756-761."},{"key":"ref7","unstructured":"8. Kumar CB, Aparna C, Srinivas P. Formulation and evaluation of solid self emulsifying drug delivery sytem of ranolazine. J Glob Tren Pharm Sci. 2014;5:2238-2247."},{"key":"ref8","unstructured":"9. Bidada J, Gonjari I, Bhusari A, Raut C. Dhule A. Development of extended release matrix tablets of ranolazine containing polyacrylic and ethylcellulose polymers. Der Pharm Let. 2011;3:215-226."},{"key":"ref9","unstructured":"10. Kuchekar SB, Mohite SK. Design and evaluation of extended release ranolazine liquisoloid tablets using placket burman screening design. Asian J Pharm Clin Res. 2015;8:292-300."},{"key":"ref10","unstructured":"11. Rahman M, Hasan S, Alam A, Roy S, Kumar Jha M, Ahsan Q, Rahman H. Formulation and evaluation of ranolazine sustained release matrix tablets using Eudragit and HPMC. Int J Pharm Biomed Res. 2011;1:172-177."},{"key":"ref11","unstructured":"12. Pittala B, Bommagani NK, Vasudeva Murthy S, Basani M, Nagavalli P. Formulation and evaluation of ranolazine extended release tablets by using pH dependent and independent polymers. Int J Pharm Bio Arc. 2013;4:1164-1171."},{"key":"ref12","unstructured":"13. Asaduzzaman, Rahman R, Khan SR, Islam SMA. Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: in vitro drug release and kinetic approach. J App Pharm Sci. 2011;1:131-136."},{"key":"ref13","unstructured":"14. Priya MR, Natarajan R, Rajendran NN. Design and in vitro evaluation of sustained release tablets of ranolazine. Int J Pharm Sci Res. 2011;2:922-928."},{"key":"ref14","unstructured":"15. Gunda RK. Formulation development and evaluation of rosiglitazone maleate sustained release tablets using 32 factorial design. Int J Pharm Tech Res. 2015;8:713-724."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4274\/tjps.galenos.2019.70048","article-title":"Statistical design and optimization of sustained release formulations of pravastatin","volume":"17","author":"RK","year":"2020","unstructured":"16. Gunda RK, Manchineni PR. Statistical design and optimization of sustained release formulations of pravastatin. Turk J Pharm Sci. 2020;17:221-227.","journal-title":"Turk J Pharm Sci"},{"key":"ref16","unstructured":"17. Kumar GR, Vijayalakshmi A. Formulation and evaluation of gastro retentive floating drug delivery system for novel fluoroquinolone using natural and semisynthetic polymers. Iran J Pharm Sci. 2020;16:49-60."},{"key":"ref17","unstructured":"18. Gunda RK, Vijayalakshmi A. Development and evaluation of gastroretentive formulations for moxifloxacin. hydrochloride. Thai J Pharm Sci. 2020;44:30-39."},{"key":"ref18","unstructured":"19. Gunda Kumar R, Kumar JNS. Formulation development and evaluation of doxofylline sustained release tablets. FABAD J Pharm Sci. 2017;42:199-208."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Babu AK, Ramana MV. In vitro and in vivo evaluation of quetiapine fumarate controlled gastroretentive floating drug delivery system. Int J Drug Del. 2016;8:12-22.","DOI":"10.22159\/ijpps.2016v8i11.9810"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Ramana M, Babu A, Thadanki M. Formulation development and evaluation of omeprazole microspheres by using the pH sensitive enteric polymers. The FASEB Jour-nal, 28: LB590. doi.org\/10.1096\/fasebj.28.1_supplement.lb590","DOI":"10.1096\/fasebj.28.1_supplement.lb590"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:59:34Z","timestamp":1717678774000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2021.58047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,29]]},"published-print":{"date-parts":[[2022,4,29]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2021.58047","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"type":"print","value":"1304-530X"},{"type":"electronic","value":"2148-6247"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}